Buy this healthcare stock on weakness: Mizuho
Mizuho reiterated an Outperform rating and $19 price target on one key healthcare stock name, telling investors the stock's recent ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
